Tillotts Pharma AG clinical trials
Acquired by Zeria Pharmaceutical, Sep 2009 · source ↗
The registry lists 10 studies whose lead sponsor is Tillotts Pharma AG. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 8, 2018.
Before and after it joined Zeria Pharmaceutical
- First submitted before Tillotts Pharma AG became part of Zeria Pharmaceutical
- 2
- First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- 8
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Tillotts Pharma AG10 studies
Something wrong with this grouping? Tell us on the Zeria Pharmaceutical page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Zeria Pharmaceutical studies →
- TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)CompletedNCT01903252Phase 3
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative ColitisCompletedNCT01059344Phase 3
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate CapsulesCompletedNCT02911298Phase 1
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- TP0502-B-Pharmaco-Scintigraphic-StudyCompletedNCT02306798Phase 1
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- TP0501 - Pharmaco-Scintigraphic-StudyCompletedNCT02306772Phase 1
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- TP0502-Pharmaco-Scintigraphic-Study and AmendmentCompletedNCT02306785Phase 1
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- Comparative Efficacy and Safety Study in Patients With Active Ulcerative ColitisCompletedNCT01257386Phase 3
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission PhaseCompletedNCT01257399Phase 3
Sponsor listed in the registry: Tillotts Pharma AG · First submitted after Tillotts Pharma AG became part of Zeria Pharmaceutical
- EPANOVA in Crohn's Disease, Study 1CompletedNCT00613197Phase 3
Sponsor listed in the registry: Tillotts Pharma AG · First submitted before Tillotts Pharma AG became part of Zeria Pharmaceutical
- An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's DiseaseCompletedNCT00074542Phase 3
Sponsor listed in the registry: Tillotts Pharma AG · First submitted before Tillotts Pharma AG became part of Zeria Pharmaceutical